星宇控股(02346.HK)接獲聯交所復牌指引
格隆匯6月29日丨星宇控股(02346.HK)公佈,於2022年6月28日,公司接獲聯交所提出的以下復牌指引:
(a)刊發上市規則要求的但尚未發佈的所有財務業績及處理任何審核修訂;
(b)證明公司遵守上市規則第13.24條;
(c)遵守上市規則第3.10(2)、3.21及3.27A條的規定;及(d)向市場提供所有重要信息,以便公司股東和其他投資者評估公司的狀況。
聯交所表示,在公司證券獲准恢復買賣之前,必須滿足所有復牌指引的要求、補救導致其暫停買賣之事宜並全面遵守上市規則致聯交所滿意。就此目的,公司有主要責任制定復牌行動計劃。聯交所亦表示,倘公司情況有變,聯交所可能修訂復牌指引或對復牌指引作出補充。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.